The FDA may change pharmacists' access to prescribing information: a website would replace paper package inserts.
نویسنده
چکیده
Pharmacist access to prescribing information may change.
منابع مشابه
The Food and Drug Administration Amendments Act of 2007: drug safety and health-system pharmacy implications: introduction.
PURPOSE To describe the drug safety provisions of the Food and Drug Administration Amendments Act (FDAAA) of 2007, including risk evaluation and mitigation strategies (REMS), and the implications for health-system pharmacists. SUMMARY The FDAAA grants FDA new authorities to require postmarketing studies or clinical trials of human drugs and to require REMS. The REMS provisions of the FDAAA re...
متن کاملBlack Box Warnings in Prescription Drug Labeling:
Prescription drugs are unavoidably associated with adverse effects, but the benefits of using such drugs outweigh the accompanying risks so long as the expert judgment of a licensed practitioner is first applied in the decision to use a drug for a particular patient. Most risks for prescription drugs appear in descending order of importance in the drug’s labeling, i.e., the package insert. The ...
متن کاملAttitudes of Pharmacists towards Patient Package Insert in Iranian Drug Packages
Background and purpose: A drug brochure or Patient Package Insert (PPI) is a sheet of paper in drug package that provides necessary information for effective and afe use of drugs. PPIs are among the main sources of drug information for general public, so, they should be clear and comprehensible. The purpose of this study was to assess the attitudes of pharmacists about PPIs in Iranian drug pac...
متن کاملDesign and evaluation of a pharmacogenomics information resource for pharmacists
Objective To develop and evaluate a pharmacogenomics information resource for pharmacists. Materials and Methods We built a pharmacogenomics information resource presenting Food and Drug Administration (FDA) drug product labelling information, refined it based on feedback from pharmacists, and conducted a comparative usability evaluation, measuring task completion time, task correctness and p...
متن کاملAn evaluation of pharmacogenomic information provided by five common drug information resources.
INTRODUCTION This study evaluated whether pharmacogenomic information contained in the Food and Drug Administration (FDA)-approved package inserts of sixty-five drugs was present in five drug information resources. METHODS The study searched for biomarkers from the FDA package inserts in 5 drug information sources: American Hospital Formulary Service Drug Information (AHFS), Facts & Compariso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 40 6 شماره
صفحات -
تاریخ انتشار 2015